Future Prospects of the Bone Morphogenetic Proteins Market: Key Trends and Growth Opportunities
The Bone Morphogenetic Proteins market is expected to grow from USD 542.3 million in 2020 to USD 633.1 million by 2026, at a CAGR of 2.6%. North America held a significant market share in 2020 and is projected to continue growing due to rising healthcare expenditure, increased awareness of minimally invasive procedures, advanced technology adoption, strong infrastructure, and favorable reimbursement.